61 results
Page 2 of 4
8-K
EX-99.1
lyupy 3wvmcr
17 Dec 21
Pulmatrix Announces Closing of $6.75 Million Registered Direct Offering
4:40pm
424B5
rzu2xufdx3u1ywd3
17 Dec 21
Prospectus supplement for primary offering
6:13am
DEFA14A
EX-99.1
exnei0bojqi ybn
15 Dec 21
Additional proxy soliciting materials
5:27pm
8-K
EX-99.1
8qe1 mmfqcoez
15 Dec 21
Pulmatrix Announces $6.75 Million Registered Direct Offering
5:27pm
8-K
EX-99.1
owvd2
10 Nov 21
Pulmatrix Reports Third Quarter 2021 Financial Results and Provides Business Update
4:20pm
8-K
EX-99.1
k1u0buk7v9xgr17i
9 Nov 21
Pulmatrix Announces Resolution of Contract Dispute with Cipla
9:15am
8-K
EX-99.1
ffaezq4a3t9uw5jvs6n
10 Aug 21
Pulmatrix Reports Second Quarter 2021 Financial Results and Provides Business Update
9:15am
8-K
EX-99.1
q71kv o6g
27 Jul 21
Departure of Directors or Certain Officers
12:26pm
8-K
EX-99.1
x81x4nyejz9vef
11 May 21
Pulmatrix Reports First Quarter 2021 Financial Results and Provides Business Update
4:40pm
8-K
EX-99.2
5w93zihi xwjiz
12 Apr 21
Termination of a Material Definitive Agreement
9:15am
8-K
EX-99.1
iklsuncjswi7j1rb91g
23 Mar 21
Pulmatrix Reports 2020 Financial Results and Provides Business Update
9:15am
8-K
EX-99.2
f7r9uc6czk3jh
4 Mar 21
Regulation FD Disclosure
9:55am
8-K
EX-99.2
ixxauwu
16 Feb 21
Entry into a Material Definitive Agreement
4:30pm
8-K
EX-99.3
be3hc
16 Feb 21
Entry into a Material Definitive Agreement
4:30pm
424B5
mbnajop03g7ar 9luou
16 Feb 21
Prospectus supplement for primary offering
7:30am